🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 221015100
- Market Cap
- Micro Cap
- IPO
- 3/23/2016 · $15.00/share
Business: Corvus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of novel agents that target the immune system to treat patients with cancer. The Company is developing drugs and antibodies that block crucial immune checkpoints, and reprogram immune T-cells.
Company Contact
- CEO
- Richard A. Miller
- CFO
- Leiv Lea
- Headquarters
- 869 Mitten Road, Suite 102, Burlingame, CA 94010
- Phone
- 650-900-4520
- Investor Relations
- Leiv Lea · 650-900-4522 · LLea@corvuspharma.com